Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Clinical trial NCT00066417 · TERMINATED

Trial details

NCT number: NCT00066417
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Myelodysplastic/Myeloproliferative Diseases

Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.